VieCure is excited to announce its Clinical Advisory Council!
August 19, 2019
The CAC comprises global leaders from top cancer programs who review clinical evidence and literature to develop algorithms and codified clinical rules for VCurePrecision™.
Cancer care is complex and ever-changing, particularly with recent advances in tumor biology and the development and approval of novel treatments guided by molecular testing. Due to this complexity, a conglomerate of the brightest minds is needed to understand and steer the future of the industry as there is far too much information for any one individual to master. VieCure’s Clinical Advisory Council comprises global leaders from top cancer programs, universities, and institutes who review clinical evidence, evaluate literature, and research Oncology treatments to develop algorithms and codified clinical rules to be actioned within the VCurePrecision™ AI platform.
Why does VieCure need a Clinical Advisory Council?
Assist in creating and updating evidence-based treatment plans, rules, and algorithms for the VieCure clinical inference engine to facilitate cutting-edge point-of-care decision making from diagnostics through survivorship.
Analyze de-identified clinical data to expose opportunities such as potential new targets for
research and treatment
Leverage professional network to improve patient care by providing strategic advice on new directions in cancer care and research across the globe
How will patients benefit from VieCure's Clinical Advisory Council?
Oncologists have access to personalized patient treatment plans based on the most recent advances in Cancer Medicine to optimize success
Side-effects of cancer therapy are managed using the tools within the VieCure platform to aid in toxicity management, monitor treatment compliance, and not only achieve better outcomes, but also improve patient quality of life throughout the course of their treatment
Facilitate ongoing education by providing easy access to clinical providers the most current information regarding the patient’s disease, treatment, and supportive care